A unique opportunity to save countless lives and billions of dollars is being overlooked by the medical community. This technique increases blood fl ow to the heart, strengthens the circulation, and offers a proven way to treat heart disease [...]
Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB), a leader in the noninvasive treatment and management of cardiovascular diseases, today announced that five presentations on the beneficial effects and the mechanisms of action of EECP [...]
AtCor Medical Holdings Limited (ASX:ACG), the developer and marketer of the SphygmoCor® system which measures central blood pressures non-invasively, has strengthened its Asian sales network [...]
Sydney-headquartered AtCor Medical develops products for clinical use that can non-invasively assess the physiological status and the functioning of the cardiovascular system in humans [...]
EECP THERAPY uses a proprietary technology to inflate and deflate a series of pneumatic cuffs enclosing the lower extremities of the patients. Treatment is administered on a padded table in which three sets of electronically controlled inflation and deflation valves are located.
